Sterwin Medicines

Manufacturer / marketing-authorisation holder

Sterwin Medicines — 63 products across 1 markets, 3 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

Sterwin Medicines — 63 productos en 1 mercados, 3 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

Sterwin Medicines —— 共 63 个产品,覆盖 1 个市场、3 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

63 products · 1 markets · 3 brand names

63 productos · 1 mercados · 3 marcas

63 个产品 · 1 个市场 · 3 个品牌名

Products by country

GB (63 records)

Source: isd.digital.nhs.uk

BrandActive ingredient(s)Form
Fortral 50mg suppositories喷他佐辛suppository
Slofedipine 20mg tablets硝苯地平tablet
Slofenac 75mg SR tablets双氯芬酸tablet
—阿替洛尔tablet
—阿替洛尔tablet
—阿替洛尔tablet
—富马酸比索洛尔tablet
—富马酸比索洛尔tablet
—卡托普利tablet
—盐酸塞利洛尔tablet
—盐酸塞利洛尔tablet
—卡托普利tablet
—卡托普利tablet
—盐酸雷尼替丁tablet
—盐酸雷尼替丁tablet
—奥美拉唑capsule
—奥美拉唑capsule
—奥美拉唑capsule
—Dosulepincapsule
—Dosulepintablet
—双氯芬酸tablet
—甲磺酸多沙唑嗪tablet
—甲磺酸多沙唑嗪tablet
—格列齐特tablet
—双氯芬酸tablet
—环丙沙星tablet
—环丙沙星tablet
—环丙沙星tablet
—环丙沙星tablet
—Aciclovirtablet
—Aciclovirtablet
—Aciclovirtablet
—布洛芬tablet
—布洛芬tablet
—阿司匹林tablet
—盐酸地尔硫卓tablet
—萘普生tablet
—盐酸西替利嗪tablet
—奥昔布宁tablet
—奥昔布宁tablet
—Lofepraminetablet
—贝诺酯liquid
—贝诺酯tablet
—盐酸司来吉兰tablet
—芬布芬tablet
—芬布芬tablet
—奥美拉唑tablet
—奥美拉唑tablet
—奥美拉唑tablet
—Fenofibrate Micronisedcapsule
—喷他佐辛capsule
—喷他佐辛suppository
—辛伐他汀tablet
—辛伐他汀tablet
—辛伐他汀tablet
—甲磺酸多沙唑嗪tablet
—Aciclovirtablet
—苯磺酸氨氯地平tablet
—苯磺酸氨氯地平tablet
—Co-Codamoleffervescent

Showing the first 60 of 63 products (ordered by country).

Mostrando los primeros 60 de 63 productos (orden por país).

仅显示前 60 / 63 个产品(按国家排序)。

Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.